- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Afinitor,
Total 220 results
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma (mRCC)Norway
-
The University of Texas Health Science Center at...Available
-
The University of Texas Health Science Center at...Temporarily not availableGastrointestinal Stromal Tumor
-
Washington University School of MedicineTyrogenexTerminatedAdenocarcinoma | Pancreatic NeoplasmsUnited States
-
Centre Francois BaclesseUniversity Hospital, CaenTerminatedRelation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell CarcinomaRenal Cell CarcinomaFrance
-
Dana-Farber Cancer InstituteNovartis PharmaceuticalsCompletedTuberous Sclerosis Complex | TSC1 | TSC2 | MTORUnited States
-
NYU Langone HealthNovartis Pharmaceuticals; The Children's Tumor FoundationCompletedNeurofibromatosis Type IIUnited States
-
Guangdong Provincial People's HospitalNovartisUnknownNeuroendocrine Tumors | Carcinoid TumorChina
-
Novartis PharmaceuticalsNo longer availableAdvanced Hormone Receptor Positive (HR+) Breast Cancer
-
New Mexico Cancer Care AllianceNovartisTerminatedMultiple Myeloma in RelapseUnited States
-
SoVarGen Co., Ltd.CompletedPharmacokineticsKorea, Republic of
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKTerminatedMetastatic Clear Cell Renal CarcinomaUnited Kingdom
-
Sidnei EpelmanUnknownRefractory or Relapsed OsteosarcomaBrazil
-
howard safranThe Miriam Hospital; Rhode Island Hospital; Memorial Hospital of Rhode Island; Roger...TerminatedHead and Neck CancerUnited States
-
NYU Langone HealthCompletedEpilepsy | Tuberous Sclerosis Complex | Focal Cortical DysplasiaUnited States
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; Assign Data Management and Biostatistics GmbHCompletedNeuroendocrine Carcinoma, Grade 3 | Poorly Differentiated Malignant Neuroendocrine Carcinoma | Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3 | Neuroendocrine Carcinoma, Grade 2 [Moderately Differentiated Neuroendocrine Carcinoma]... and other conditionsGermany
-
Hopital FochCompleted
-
ExelixisCompletedRenal Cell CarcinomaUnited States, Belgium, Spain, Taiwan, Canada, Germany, Korea, Republic of, France, Austria, Chile, Australia, Hungary, Russian Federation, Italy, Turkey, Netherlands, Sweden, United Kingdom, Czechia, Ireland, Slovakia, Argentina, D... and more
-
Sidnei EpelmanUnknownRefractory or Relapsed RMS and Soft Tissue SarcomasBrazil
-
Yonsei UniversityCompletedEpilepsy and Focal Cortical Dysplasia IIKorea, Republic of
-
Novartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterNovartisActive, not recruiting
-
Swiss Group for Clinical Cancer ResearchCompletedProstate CancerSwitzerland
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma | Advanced Solid Tumors | Metastatic Breast CancerSpain, Belgium, Italy, France, United States, New Zealand, United Kingdom
-
Dana-Farber Cancer InstituteM.D. Anderson Cancer Center; Massachusetts General Hospital; Novartis; MOUNT SINAI...Completed
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Erasmus Medical CenterWithdrawnNeoplasm Metastasis | Neoplastic Processes | Peutz-Jeghers SyndromeNetherlands
-
Mustafa SahinNovartis Pharmaceuticals; Autism Speaks; Tuberous Sclerosis Alliance; Seizure Tracker...CompletedTuberous Sclerosis ComplexUnited States
-
German Breast GroupNovartisTerminatedMetastatic Breast CancerGermany
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Duke UniversityNovartis; PfizerCompletedAdvanced Non-clear Cell Renal Cell CarcinomaUnited States, Canada, United Kingdom
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerBelgium, Australia, Germany
-
M.D. Anderson Cancer CenterCompletedSolid Tumor | Advanced CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Novartis PharmaceuticalsTerminatedHepatocellular CarcinomaHong Kong, Taiwan, Thailand
-
University of UtahNovartisTerminatedPeutz-Jeghers SyndromeUnited States
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
Georgetown UniversityNovartis; University of Texas Southwestern Medical Center; Cedars-Sinai Medical... and other collaboratorsUnknownMetastatic Pancreatic AdenocarcinomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellHungary, United States, Brazil, Canada, Chile, Colombia, Czechia, Denmark, Finland, France, Germany, Hong Kong, Italy, Japan, Korea, Republic of, Norway, Russian Federation, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom
-
Mario Negri Institute for Pharmacological ResearchTerminated
-
Hannover Medical SchoolNovartisCompletedTesticular Cancer | Germ Cell CancerGermany
-
Radboud University Medical CenterCompletedRenal Cell Carcinoma | Breast CancerNetherlands
-
National Cancer Institute, SlovakiaCompleted
-
iOMEDICO AGNovartisCompletedMetastatic Renal Cell Carcinoma | Failure of Exactly One Prior VEGF-targeted TherapyGermany
-
UMC UtrechtCompletedUnspecified Adult Solid Tumor, Protocol SpecificNetherlands
-
Armando Santoro, MDCompletedThymoma and Thymic CarcinomaItaly
-
Baylor College of MedicineNovartis PharmaceuticalsWithdrawnSturge Weber SyndromeUnited States
-
Association Pour La Recherche des Thérapeutiques...CompletedClear-cell Metastatic Renal Cell Carcinoma | Clear-cell Renal CarcinomaFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); NovartisActive, not recruiting
-
Jenny C. Chang, MDThe Methodist Hospital Research InstituteCompletedBreast Cancer | Triple Negative Breast CancerUnited States
-
Hellenic Cooperative Oncology GroupNovartisTerminatedGastrointestinal Tumors | Pancreatic Neuroendocrine Tumors | Pancreatic Tumors | Gastrointestinal Neuroendocrine TumorsGreece